Janssen Pharmaceuticals, the arm of Johnson & Johnson behind the anti-seizure drug Topamax, is the target of over 100 lawsuits in the Philadelphia Court of Common Pleas. The pharmaceutical company is currently defending itself in a Topamax birth defects lawsuit involving a family from Wisconsin. The plaintiffs in the case have a child whose birth defects they allege are the result of exposure to Topamax in the womb.
According to Law360, the Wisconsin family filed their Topamax lawsuit against Janssen Pharmaceuticals claiming that the drug manufacturer neglected to adequately advise health care providers and patients about the risks associated with Topamax use during pregnancy. The most commonly reported Topamax birth defect in children exposed to the drug in the womb include oral defects, cleft lip and/or cleft palate.
The St. Louis class action attorneys at Carey Danis & Lowe represent families whose children have suffered from Topamax birth defects. We are a national law firm experienced in class action litigation, and we specialize in pharmaceutical product liability lawsuits. If your child was born with congenital birth defects as a result of Topamax exposure, we encourage you to discuss your legal options and compensation eligibility with one of our Topamax lawyers today. Our initial case evaluations are free.
Carey Danis & Lowe is available now to discuss your Topamax story. Contact Carey Danis & Lowe by phone at 800.721.2519, or by completing one of our personal injury claim forms.References: Pharmaceutical litigation, Topamax